Declaration of Competing Interest statements were not included in the published version of the following articles that appeared in previous issues of Contemporary Clinical Trials Communications.
The appropriate Declaration/Competing Interest statements, provided by the Authors, are included below.
-
1
“Evaluating the effectiveness and reliability of the Vibrant Soundbridge and Bonebridge auditory implants in clinical practice: Study design and methods for a multi-centre longitudinal observational study” [Contemporary Clinical Trials Communications, 2018; 10: 137–140] https://doi.org/10.1016/j.conctc.2018.03.007.
Declaration of competing interest: This research was partially funded by a research grant from MEDEL. This covered the cost of a part-time researcher to monitor study and enter the data. The results will be independently analysed by the Chief Investigator.
-
2
“Treatment of trauma related anger in operation enduring freedom, operation Iraqi freedom, and operation New Dawn veterans: Rationale and study protocol” [Contemporary Clinical Trials Communications, 2018; 12: 26–31].
https://doi.org/10.1016/j.conctc.2018.08.011.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
3
“Different ways to estimate treatment effects in randomised controlled trials” [Contemporary Clinical Trials Communications, 2018; 10: 80–85].https://doi.org/10.1016/j.conctc.2018.03.008.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
4
“Recruitment & retention program for the NeuroNEXT SMA Biomarker Study: Super Babies for SMA!” [Contemporary Clinical Trials Communications, 2018; 11: 113–119] https://doi.org/10.1016/j.conctc.2018.07.002.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
5
“Two-step recruitment process optimizes retention in FLEX clinical trial” [Contemporary Clinical Trials Communications, 2018; 12: 68–75].https://doi.org/10.1016/j.conctc.2018.09.005.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
6
“Design of an experimental protocol to examine medication non-adherence among young drivers diagnosed with ADHD: A driving simulator study” [Contemporary Clinical Trials Communications, 2018; 11: 149–155].https://doi.org/10.1016/j.conctc.2018.07.007.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
7
“Exercise training as S-Klotho protein stimulator in sedentary healthy adults: Rationale, design, and methodology” [Contemporary Clinical Trials Communications, 2018; 11: 10–19] https://doi.org/10.1016/j.conctc.2018.05.013.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
8
“Extensions of the mTPI and TEQR designs to include non-monotone efficacy in addition to toxicity for optimal dose determination for early phase immunotherapy oncology trials” [Contemporary Clinical Trials Communications, 2018; 10: 62–76].https://doi.org/10.1016/j.conctc.2018.01.006.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
9
“Meal-exercise challenge and physical activity reduction impact on immunity and inflammation (MERIIT trial)” [Contemporary Clinical Trials Communications, 2018; 10: 177–189] https://doi.org/10.1016/j.conctc.2018.05.010.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
10
“A randomized preference trial of cognitive-behavioral therapy and yoga for the treatment of worry in anxious older adults” [Contemporary Clinical Trials Communications, 2018; 10: 169–176] https://doi.org/10.1016/j.conctc.2018.05.002.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
11
“Promoting fruit and vegetable consumption: Methodological protocol of a randomized controlled community trial” [Contemporary Clinical Trials Communications, 2018; 10: 131–136] https://doi.org/10.1016/j.conctc.2018.04.003.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
12
“An initiative using informatics to facilitate clinical research planning and recruitment in the VA health care system” [Contemporary Clinical Trials Communications, 2018; 11: 107–112] https://doi.org/10.1016/j.conctc.2018.07.001.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
13
“Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial” [Contemporary Clinical Trials Communications, 2018; 9: 121–129] https://doi.org/10.1016/j.conctc.2018.01.007.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
14
“Master protocol trials in oncology: Review and new trial designs” [Contemporary Clinical Trials Communications, 2018; 12: 1–8].https://doi.org/10.1016/j.conctc.2018.08.009.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
15
“Embedded Motivational Interviewing combined with a smartphone app to increase physical activity in people with sub-acute low back pain: Study protocol of a cluster randomised control trial” [Contemporary Clinical Trials Communications, 2019; 17: 100511] https://doi.org/10.1016/j.conctc.2019.100511.
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.